The classical methods of assessing tumor killing by an effector T cells relies upon an estimation of the timing of this recognition and as such, this event may be missed. The ACEA xCELLigence system can be used to assess the kinetics of tumor-infiltrating lymphocyte recognition and killing of autologous or HLA-matched primary tumor cell lines, allowing for a non-biased timing approach to explore the impact of tumor-infiltrating lymphocyte modification on their killing ability.
Watch this webinar to learn how Dr. Haymaker and her team are using the ACEA xCELLigence system to:
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.